期刊文献+

B型钠尿肽基础与临床研究进展

Basic and clinical research progress of B type natriuretic peptide
原文传递
导出
摘要 目的探讨血浆B型钠尿肽(BNP)水平与心力衰竭的诊断、严重程度和预后的关系。方法选择在滨州市人民医院老年科住院的心力衰竭患者300例(治疗组),测定其入院时血浆BNP水平,并与同期健康体检者(对照组)作对比,并随访其出院后2年内因心力衰竭再住院和死亡的情况。结果治疗组BNP水平均高于健康对照组(P〈0.01);BNP水平与心功能分级关系密切,治疗组BNP水平随着心功能的加重而升高,呈明显正相关(r=0.79,P〈0.01),而左室射血分数(LYEF)随着心功能的加重而降低,呈明显负相关(r=-0.73,P〈0.01),BNP水平高的患者2年内再住院率和病死率均高。结论血浆BNP水平可以用于心力衰竭的诊断、严重程度判断和预后评估。 Objective To investigate the relationship between the levels of plasma B type natriuretic peptide (BNP) and the diagnosis, severity and prognosis in elderly inpatients with heart failure. Methods Three hundred elderly patients with heart failure were selected, the plasma BNP levels were measured on admission, and were compared with healthy controls in same period, and the heart failure readmission and death situation during 2 years after discharge was fol- lowed-up. Results The BNP level in treatment group was higher than that in healthy controls ( P 〈 O. O1 ) ; the level of BNP was closely related to cardiac functional grading, in treatment group, the level of BNP increased with the deterioration of the cardiac function, there was a positive correlation (r = 0. 79, P 〈 0.01 ) ; and LVEF decreased with deterioration of the cardiac function, there was a negative correlation ( r = - 0. 73, P 〈 0.01 ). Patients with high levels of BNP had higher rehospitalization rate and mortality with in 2 years. Conclusions The level of plasma BNP can be used for the diagnosis, severity ossessment and prognosis evaluation of heart failure.
出处 《中国实用医刊》 2014年第7期86-87,共2页 Chinese Journal of Practical Medicine
关键词 B型钠尿肽 心力衰竭 研究进展 B type natriuretic peptide Heart failure Research progress
  • 相关文献

参考文献10

  • 1Nishikimi T, Hagaman JR, Takahashi N,et al. Increased susceptibil- ity to heart failure in response to volume overload in mice lacking na- triuretic [ J]. Cardiovasc Res,2005,66( 1 ) :94-103.
  • 2Ito T, Yoshimura M, Nakamura S, et al. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonat [ J ]. Circulation, 2003, 107(6) :807-810.
  • 3Kone BC. Molecular biology of natriuretic peptides and nitric oxide synthases[J].Cardiovasc Res, 2001, 51 (3): 439-441.
  • 4Levin ER, Cardner DG, Samson WK. Natriuretic peptides [ J]. N Eng J Med,1998, 339(5) : 321-328.
  • 5Silberbach M, Roberts CT. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation[J]. Cell Signal, 2001, 13 (4) : 221-231.
  • 6Mccullough PA, Nowak RM, Mccord J, et al. B-type natriuretic pep- tide and clinical judgment in emergency diagnosis of heart failure anal- ysis from Breathing Not properly (BNP) Multinational study[ J]. Cir- culation, 2002, 106(4): 416-422.
  • 7王成刚,陈燕勤,胡文健.B型钠尿肽测定在心力衰竭诊断和治疗中的作用[J].检验医学,2005,20(6):526-528. 被引量:9
  • 8Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natri- uretic peptide in the diagnosis of congestive heart failure in an urgent- care[J]. J Am Coll Cardiol,2001, 37(2) : 379-385.
  • 9Kalra PR, Anker SD, Coats AJ. Water and sodium regulation in chro- nic heart failure : the role of natriuretic peptides and vasopress [ J ]. Cardiovasc Res, 2001, 51 (3):495-509.
  • 10Mills RM, Hobbs RE, Young JB. "BNP" for heart failure: role of nesiritide in cardiovascular therapeutics [ J ]. Congest Heart Fail, 2002, 8 (5) : 270-273.

二级参考文献11

  • 1Maisel AS, Krishnaswamy P, Nowak RM, et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. J Fam Pract,2002,51:816.
  • 2Bhatia V, Nayyar P, Dhindsa S. Brain natriuretic peptide in diagnosis and treatment of heart failure[J]. J Postgrad Med,2003,49 : 182-185.
  • 3Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure[J]. J Am Coll Cardiol,2001,37 :386-391.
  • 4Stefan KG, Jurgen G, Marc W, et al. Brain Natriuretic peptide predicts right heart failure in patients with acute aulmonary embolism[J]. Am Heart J,2004,147:60-65.
  • 5Inoue T, Sakuma M, Yanguchi I, et al. Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction[J]. Am Heart J, 2002, 143 : 790-796.
  • 6Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction[J]. Circulation,2003,107 : 2786-2792.
  • 7Keisuke K, Katsuya H, Hideyuki TK, et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy : a potential of hormone-guided treatment[J]. Am Heart J,2001,141:925-932.
  • 8De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptides in cardiovascular disease[J].Lancet, 2003,362 : 316-322.
  • 9Caboral M, Mitchell J. B-type natriuretic peptide:a new tool in the armamentarium used to accurately diagnose heart failure[J]. Prog Cardiovasc Nurs,2003,18 : 190-193.
  • 10Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-natriuretic peptide (BNP) in the diagnosis of congestive heart in an urgent care setting[J]. J Am Coll Cardiol,2001,37 :379-385.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部